CGManalyzer: an R package for analyzing continuous glucose monitoring studies

被引:44
作者
Zhang, Xiaohua Douglas [1 ]
Zhang, Zhaozhi [2 ]
Wang, Dandan [1 ]
机构
[1] Univ Macau, Fac Hlth Sci, Taipa, Macao, Peoples R China
[2] Duke Univ, Dept Stat Sci, Durham, NC 27708 USA
关键词
QUALITY;
D O I
10.1093/bioinformatics/btx826
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The R package CGManalyzer contains functions for analyzing data from a continuous glucose monitoring (CGM) study. It covers a wide and comprehensive range of data analysis methods including reading a series of datasets, obtaining summary statistics of glucose levels, plotting data, transforming the time stamp format, fixing missing values, evaluating the mean of daily difference and continuous overlapping net glycemic action, calculating multiscale sample entropy, conducting pairwise comparison, displaying results using various plots including a new type of plot called an antenna plot, etc. This package has been developed from our work in directly analyzing data from various CGM devices such as the FreeStyle Libre, Glutalor, Dexcom and Medtronic CGM. Thus, this package should greatly facilitate the analysis of various CGM studies.
引用
收藏
页码:1609 / 1611
页数:3
相关论文
共 13 条
  • [1] Complexity Change in Cardiovascular Disease
    Chen, Chang
    Jin, Yu
    Lo, Iek Long
    Zhao, Hansen
    Sun, Baoqing
    Zhao, Qi
    Zheng, Jun
    Zhang, Xiaohua Douglas
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2017, 13 (10): : 1320 - 1328
  • [2] Dynamical glucometry: Use of multiscale entropy analysis in diabetes
    Costa, Madalena D.
    Henriques, Teresa
    Munshi, Medha N.
    Segal, Alissa R.
    Goldberger, Ary L.
    [J]. CHAOS, 2014, 24 (03)
  • [3] Defining digital medicine
    Elenko, Eric
    Underwood, Lindsay
    Zohar, Daphne
    [J]. NATURE BIOTECHNOLOGY, 2015, 33 (05) : 456 - 461
  • [4] Glucose Variability in a 26-Week Randomized Comparison of Mealtime Treatment With Rapid-Acting Insulin Versus GLP-1 Agonist in Participants With Type 2 Diabetes at High Cardiovascular Risk
    Probstfield J.L.
    Hirsch I.B.
    Davis B.R.
    Ahmann A.
    Bergenstal R.
    Gilbert M.
    Kingry C.
    Khakpour D.
    Lai D.
    Pressel S.L.
    Branch K.R.
    Riddle M.
    O'Brien K.D.
    [J]. DIABETES CARE, 2016, 39 (06) : 973 - 981
  • [5] Differential HbA1c response in the placebo arm of DPP-4 inhibitor clinical trials conducted in China compared to other countries: a systematic review and meta-analysis
    He, Lingyu
    Liu, Shu
    Shan, Chun
    Tu, Yingmei
    Li, Zhengqing
    Zhang, Xiaohua Douglas
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2016, 17
  • [6] Entropy change of biological dynamics in COPD
    Jin, Yu
    Chen, Chang
    Cao, Zhixin
    Sun, Baoqing
    Lo, Iek Long
    Liu, Tzu-Ming
    Zheng, Jun
    Sun, Shixue
    Shi, Yan
    Zhang, Xiaohua Douglas
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 2997 - 3005
  • [7] McDonnell C M, 2005, Diabetes Technol Ther, V7, P253, DOI 10.1089/dia.2005.7.253
  • [8] Detection of sputum by interpreting the time-frequency distribution of respiratory sound signal using image processing techniques
    Niu, Jinglong
    Shi, Yan
    Cai, Maolin
    Cao, Zhixin
    Wang, Dandan
    Zhang, Zhaozhi
    Zhang, Xiaohua Douglas
    [J]. BIOINFORMATICS, 2018, 34 (05) : 820 - 827
  • [9] Improved Quality of Glycemic Control and Reduced Glycemic Variability with Use of Continuous Glucose Monitoring
    Rodbard, David
    Bailey, Timothy
    Jovanovic, Lois
    Zisser, Howard
    Kaplan, Roy
    Garg, Satish K.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 (11) : 717 - 723
  • [10] Zhang X.D., 2011, OPTIMAL HIGH THROUGH